Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Mark A. Grise"'
Autor:
Stephen R. Ramee, Paul W. McMullan, J. Stephen Jenkins, Tyrone J. Collins, Ramy A. Badawi, Christopher J. White, Mark A. Grise, John P. Reilly
Publikováno v:
Catheterization and Cardiovascular Interventions. 80:121-127
Background: Current “best” medical therapy with anti-platelet and/or anti-thrombotic agents for symptomatic atherosclerotic intracranial (IC) disease is associated with high recurrence. IC catheter-based therapy (CBT) using balloon angioplasty wi
Autor:
Christopher J. White, Stephen R. Ramee, Anil Verma, Tyrone J. Collins, J. Stephen Jenkins, John P. Reilly, Paul W. McMullan, Christopher L Paris, Mark A. Grise
Publikováno v:
Vascular Medicine. 16:109-112
The objective of this paper is to describe outcomes of endovascular therapy in patients with symptomatic common femoral artery (CFA) lesions. Symptomatic atherosclerotic disease of the common femoral artery is an uncommon clinical entity, and there i
Autor:
Stephen R. Ramee, Samir N. Patel, Christopher J. White, Tyrone J. Collins, J. Stephen Jenkins, Paul W. McMullan, John P. Reilly, Mark A. Grise, Arthur G. Grant
Publikováno v:
Journal of the American College of Cardiology. 55(6):538-542
Objectives The aim of this study was to demonstrate the safety and long-term durability of catheter-based therapy for symptomatic vertebral artery stenosis (VAS). Background Symptomatic VAS carries with it a 5-year 30% to 35% risk of stroke. The 2-ye
Autor:
Paul W. McMullan, Mark A. Grise, John P. Reilly, Christopher J. White, Stephen R. Ramee, Carlos A. Velez, J. Stephen Jenkins, Tyrone J. Collins
Publikováno v:
Catheterization and Cardiovascular Interventions. 72:303-308
Background: Carotid artery stent (CAS) placement is an alternative to carotid endarterectomy (CEA) for stroke prevention. Clinical adoption of CAS depends on its safety and efficacy compared to CEA. There are conflicting reports in the literature reg
Autor:
Gary L. Schaer, Jeffrey M. Isner, Douglas W. Losordo, Timothy Henry, F. David Fortuin, John Lopez, Wayne E. Richenbacher, Richard A. Schatz, Joseph R. Van Camp, Mark A. Grise, Peter R. Vale, John P. Reilly
Publikováno v:
Journal of Interventional Cardiology. 18:27-31
Background: The short-term clinical impact of intramyocardial gene transfer (GT) of the angiogenic protein vascular endothelial growth factor-2 (VEGF-2) has been previously reported to significantly reduce Canadian Cardiovascular Society (CCS) angina
Autor:
Jonathan M. Tobis, Paul S. Teirstein, Mark A. Grise, Martin B. Leon, Jeffrey W. Moses, Giora Weisz, John P. Reilly, Jon A. Kobashigawa, Alan C. Yeung, Yuzuru Takano, Jesse Currier
Publikováno v:
Catheterization and Cardiovascular Interventions. 60:41-44
Transplant vasculopathy significantly limits the survival of cardiac transplant patients and occurs in 50% of patients by 5 years posttransplant. We report our experience with six cardiac transplant patients who underwent intracoronary brachytherapy
Autor:
Martin B. Leon, Jeffrey J. Popma, Mark A. Grise, Richard A. Schatz, David A. Cloutier, Prabhakar Tripuraneni, Paul S. Teirstein, Shirish Jani, Stephen Steuterman, Erminia M. Guarneri, Robert J. Russo, Vincent Massullo
Publikováno v:
Circulation. 105:2737-2740
Background — Several clinical trials indicate that intracoronary radiation is safe and effective for treatment of restenotic coronary arteries. We previously reported 6-month and 3-year clinical and angiographic follow-up demonstrating significant
Autor:
Richard A. Schatz, Paul S. Teirstein, Mindy R. Fernandez, Prabhtej Brara, Mark A. Grise, John P. Reilly, Mehran Moussavian
Publikováno v:
Circulation. 107:1722-1724
Background— Sirolimus-coated stents are a promising new therapy for restenosis. We treated a select group of patients at especially high risk for restenosis with oral sirolimus. Methods and Results— Patients were treated with an oral sirolimus-lo
Publikováno v:
Catheterization and Cardiovascular Interventions. 57:31-33
Autor:
Stephen R. Ramee, J. Stephen Jenkins, Paul W. McMullan, Tyrone J. Collins, Rajan A.G. Patel, Stanley N. Thornton, John P. Reilly, Mark A. Grise, Christopher J. White, Zehra Jaffery
Publikováno v:
Vascular medicine (London, England). 16(5)
Clinically evident and subclinical peri-procedural bleeding following interventional therapies are associated with adverse cardiovascular outcomes. The risk factors for clinically evident bleeding have been well described. Despite the well-documented